The GH receptor exon 3 deleted/full-length polymorphism is associated with central adiposity in the general population

European Journal of Endocrinology

Volumn 172, Issue 2, 2015, Pages 123-128

  Glad, Camilla A M ^a   Carlsson, Lena M S ^a   Melander, Olle ^b   Almgren, Peter ^b   Sjöström, Lars ^a   Nilsson, Staffan ^c   Larsson, Ingrid ^a   Svensson, Per Arne ^a   Johannsson, Gudmundur ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GROWTH HORMONE RECEPTOR; INSULIN;

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DNA POLYMORPHISM; EXON; FAT FREE MASS; FEMALE; FULL LENGTH POLYMORPHISM; GENE DELETION; GENETIC ASSOCIATION; GENETIC MODEL; GENOTYPE PHENOTYPE CORRELATION; GHR GENE; HOMOZYGOSITY; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; TOTAL BODY POTASSIUM; WAIST CIRCUMFERENCE; WAIST HIP RATIO; AGED; COHORT ANALYSIS; EPIDEMIOLOGY; GENETICS; HEALTH SURVEY; MIDDLE AGED; OBESITY, ABDOMINAL; PROCEDURES; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SWEDEN;

AGED; COHORT STUDIES; CROSS-SECTIONAL STUDIES; EXONS; FEMALE; GENE DELETION; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MIDDLE AGED; OBESITY, ABDOMINAL; POLYMORPHISM, SINGLE NUCLEOTIDE; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RECEPTORS, SOMATOTROPIN; SWEDEN;

EID: 84922513349     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-14-0723     Document Type: Article

References (37)

1. Giustina A & Veldhuis JD. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocrine Reviews 1998 19 717-797. (doi:10.1210/edrv.19.6.0353)
2. Isaksson OG, Jansson JO & Gause IA. Growth hormone stimulates longitudinal bone growth directly. Science 1982 216 1237-1239. (doi:10.1126/science.7079756)
3. Vahl N, Jorgensen JO, Skjaerbaek C, Veldhuis J.D., Orskov H & Christiansen JS. Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults. American Journal of Physiology 1997 272 E1108-E1116.
4. Franco C, Bengtsson BA & Johannsson G. The GH/IGF-1 axis in obesity: physiological and pathological aspects. Metabolic Syndrome and Related Disorders 2006 4 51-56. (doi:10.1089/met.2006.4.51)
5. Johannsson G, Marin P, Lonn L., Ottosson M, Stenlof K, Bjorntorp P., Sjostrom L & Bengtsson BA. Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. Journal of Clinical Endocrinology and Metabolism 1997 82 727-734. (doi:10.1210/jcem.82.3.3809)
6. Johannsson G. Management of adult growth hormone deficiency. Endocrinology and Metabolism Clinics of North America 2007 36 203-220. (doi:10.1016/j.ecl.2006.11.012)
7. Barton DE, Foellmer BE, Wood WI & Francke U. Chromosome mapping of the growth hormone receptor gene in man and mouse. Cytogenetics and Cell Genetics 1989 50 137-141. (doi:10.1159/000132743)
8. Godowski PJ, Leung DW, Meacham L.R., Galgani JP, Hellmiss R, Keret R, Rotwein P.S., Parks JS, Laron Z & Wood WI. Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. PNAS 1989 86 8083-8087. (doi:10.1073/pnas.86.20.8083)
9. Bazan JF. Structural design and molecular evolution of a cytokine receptor superfamily. PNAS 1990 87 6934-6938. (doi:10.1073/pnas.87.18.6934)
10. de Vos A.M., Ultsch M & Kossiakoff AA. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 1992 255 306-312. (doi:10.1126/science.1549776)
11. Pantel J, Machinis K, Sobrier M.L., Duquesnoy P., Goossens M & Amselem S. Species-specific alternative splice mimicry at the growth hormone receptor locus revealed by the lineage of retroelements during primate evolution. Journal of Biological Chemistry 2000 275 18664-18669. (doi:10.1074/jbc.M001615200)
12. Dos Santos C., Essioux L, Teinturier C., Tauber M, Goffin V & Bougneres P. A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nature Genetics 2004 36 720-724. (doi:10.1038/ng1379)
13. van der Klaauw AA, van der Straaten T, Baak-Pablo R, Biermasz NR, Guchelaar HJ, Pereira AM, Smit JW & Romijn JA. Influence of the d3-growth hormone (GH) receptor isoform on short-term and long-term treatment response to GH replacement in GH-deficient adults. Journal of Clinical Endocrinology and Metabolism 2008 93 2828-2834. (doi:10.1210/jc.2007-2728)
14. Glad CA, Barbosa EJ, Filipsson Nystrom H, Carlsson LM, Nilsson S, Nilsson A.G., Svensson PA & Johannsson G. SNPs within the GH-signaling pathway are associated with the early IGF1 response to GH replacement therapy in GHD adults. European Journal of Endocrinology 2014 170 101-107. (doi:10.1530/EJE-13-0685)
15. Renehan AG, Solomon M, Zwahlen M., Morjaria R, Whatmore A, Audi L., Binder G, Blum W, Bougneres P, Santos CD et al. Growth hormone receptor polymorphism and growth hormone therapy response in children: a Bayesian meta-analysis. American Journal of Epidemiology 2012 175 867-877. (doi:10.1093/aje/kwr408)
16. Wassenaar MJ, Dekkers OM, Pereira A.M., Wit JM, Smit JW, Biermasz NR & Romijn JA. Impact of the exon 3-deleted growth hormone (GH) receptor polymorphism on baseline height and the growth response to recombinant human GH therapy in GH-deficient (GHD) and non-GHD children with short stature: a systematic review and meta-analysis. Journal of Clinical Endocrinology and Metabolism 2009 94 3721-3730. (doi:10.1210/jc.2009-0425)
17. Sjostrom L, Larsson B, Backman L., Bengtsson C, Bouchard C, Dahlgren S., Hallgren P, Jonsson E, Karlsson J, Lapidus L et al. Swedish obese subjects (SOS). Recruitment for an intervention study and a selected description of the obese state. International Journal of Obesity and Related Metabolic Disorders 1992 16 465-479.
18. Larsson I, Berteus Forslund H, Lindroos AK, Lissner L, Naslund I., Peltonen M & Sjostrom L. Body composition in the SOS (Swedish Obese Subjects) reference study. International Journal of Obesity and Related Metabolic Disorders 2004 28 1317-1324. (doi:10.1038/sj.ijo.0802732)
19. Kvist H, Chowdhury B, Sjostrom L., Tylen U & Cederblad A. Adipose tissue volume determination in males by computed tomography and 40K. International Journal of Obesity 1988 12 249-266.
20. Sjostrom L, Kvist H, Cederblad A & Tylen U. Determination of total adipose tissue and body fat in women by computed tomography, 40K, and tritium. American Journal of Physiology 1986 250 E736-E745.
21. Berglund G, Elmstahl S, Janzon L & Larsson SA. The Malmo Diet and Cancer Study. Design and feasibility. Journal of Internal Medicine 1993 233 45-51. (doi:10.1111/j.1365-2796.1993.tb00647.x)
22. Rosvall M, Janzon L, Berglund G., Engstrom G & Hedblad B. Incident coronary events and case fatality in relation to common carotid intima-media thickness. Journal of Internal Medicine 2005 257 430-437. (doi:10.1111/j.1365-2796.2005.01485.x)
23. Glad CA, Johannsson G, Carlsson LM & Svensson PA. Rapid and high throughput genotyping of the growth hormone receptor exon 3 deleted/full-length polymorphism using a tagSNP. Growth Hormone & IGF Research 2010 20 270-273. (doi:10.1016/j.ghir.2010.02.004)
24. Bengtsson BA, Eden S, Lonn L., Kvist H, Stokland A, Lindstedt G., Bosaeus I, Tolli J, Sjostrom L & Isaksson OG. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. Journal of Clinical Endocrinology and Metabolism 1993 76 309-317. (doi:10.1210/jcem.76.2.8432773)
25. Clasey JL, Weltman A, Patrie J., Weltman JY, Pezzoli S, Bouchard C, Thorner MO & Hartman ML. Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors. Journal of Clinical Endocrinology and Metabolism 2001 86 3845-3852. (doi:10.1210/jcem.86.8.7731)
26. Vahl N, Jorgensen JO, Jurik AG & Christiansen JS. Abdominal adiposity and physical fitness are major determinants of the age associated decline in stimulated GH secretion in healthy adults. Journal of Clinical Endocrinology and Metabolism 1996 81 2209-2215. (doi:10.1210/jcem.81.6.8964853)
27. Iranmanesh A, Lizarralde G & Veldhuis JD. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. Journal of Clinical Endocrinology and Metabolism 1991 73 1081-1088. (doi:10.1210/jcem-73-5-1081)
28. Veldhuis JD, Iranmanesh A, Ho KK, Waters MJ, Johnson ML & Lizarralde G. Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. Journal of Clinical Endocrinology and Metabolism 1991 72 51-59. (doi:10.1210/jcem-72-1-51)
29. Williams T, Berelowitz M, Joffe S.N., Thorner MO, Rivier J, Vale W & Frohman LA. Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. New England Journal of Medicine 1984 311 1403-1407. (doi:10.1056/NEJM198411293112203)
30. Makimura H, Stanley T, Mun D., Chen C, Wei J, Connelly J.M., Hemphill LC & Grinspoon SK. Reduced growth hormone secretion is associated with increased carotid intima-media thickness in obesity. Journal of Clinical Endocrinology and Metabolism 2009 94 5131-5138. (doi:10.1210/jc.2009-1295)
31. Miller KK, Biller BM, Lipman J.G., Bradwin G., Rifai N & Klibanski A. Truncal adiposity, relative growth hormone deficiency, and cardiovascular risk. Journal of Clinical Endocrinology and Metabolism 2005 90 768-774. (doi:10.1210/jc.2004-0894)
32. Utz AL, Yamamoto A, Hemphill L & Miller KK. Growth hormone deficiency by growth hormone releasing hormone-arginine testing criteria predicts increased cardiovascular risk markers in normal young overweight and obese women. Journal of Clinical Endocrinology and Metabolism 2008 93 2507-2514. (doi:10.1210/jc.2008-0169)
33. Weltman A, Despres JP, Clasey J.L., Weltman JY, Wideman L, Kanaley J, Patrie J., Bergeron J, Thorner MO, Bouchard C et al. Impact of abdominal visceral fat, growth hormone, fitness, and insulin on lipids and lipoproteins in older adults. Metabolism 2003 52 73-80. (doi:10.1053/meta.2003.50007)
34. Goh LG, Dhaliwal SS, Welborn T.A., Lee AH & Della PR. Anthropometric measurements of general and central obesity and the prediction of cardiovascular disease risk in women: a cross-sectional study. BMJ Open 2014 4 e004138. (doi:10.1136/bmjopen-2013-004138)
35. Shen Y, Wang L, Zhao Y., You L, Geng L, Gu HF & Chen ZJ. Evaluation of the association between GHR exon 3 polymorphism and polycystic ovary syndrome among Han Chinese women. Growth Hormone & IGF Research 2011 21 248-251. (doi:10.1016/j.ghir.2011.07.002)
36. Strawbridge RJ, Karvestedt L, Li C., Efendic S, Ostenson CG, Gu HF & Brismar K. GHR exon 3 polymorphism: association with type 2 diabetes mellitus and metabolic disorder. Growth Hormone & IGF Research 2007 17 392-398. (doi:10.1016/j.ghir.2007.04.005)
37. Gao L, Zheng Z, Cao L., Shen S, Yang Y, Zhao Z., Zhi D, Cheng R, Pei Z, Yongfu Y et al. The growth hormone receptor (GHR) exon 3 polymorphism and its correlation with metabolic profiles in obese Chinese children. Pediatric Diabetes 2011 12 429-434. (doi:10.1111/j.1399-5448.2010.00747.x)